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Substitution of Glu122 by glutamine revealed the function of the second water molecule 
as a proton donor in the binuclear metal enzyme, creatininase.  
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Creatininase is a binuclear zinc enzyme and catalyzes the reversible conversion of 
creatinine to creatine. It exhibits an open-closed conformational change upon substrate 
binding and the differences in the conformations of Tyr121, Trp154, and the loop region 
containing Trp174 were evident in the enzyme-creatine complex when compared to 
those in the ligand-free enzyme. We have determined the crystal structure of the enzyme 
complexed with a 1-methylguanidine. All subunits in the complex existed as the closed 
form, and the binding mode of creatinine was estimated. Site-directed mutagenesis 
revealed that the hydrophobic residues that show conformational change upon substrate 
binding are important for the enzyme activity.  
We propose a catalytic mechanism of creatininase in which two water molecules 
have significant roles. The first molecule is a hydroxide ion (Wat1) that is bound as a 
bridge between the two metal ions, and attacks the carbonyl carbon of the substrate. The 
second molecule is a water molecule (Wat2) that is bound to the carboxyl group of 
Glu122 and functions as a proton donor in catalysis. The activity of the E122Q mutant 
was very low and it was only partially restored by the addition of ZnCl2 or MnCl2. In 
E122Q mutant, kcat is drastically decreased, indicating that Glu122 is important for 
catalysis. X-ray crystallographic study and the atomic absorption spectrometry analysis 
of the E122Q mutant-substrate complex revealed that the drastic decrease of the activity 
of the E122Q was caused by not only the loss of one Zn ion at the Metal1 site but also a 
critical function of Glu122, which most likely exists for a proton transfer step through 
the Wat2.  
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Creatininase (creatinine amidohydrolase: [EC 3.5.2.10]) is a binuclear zinc enzyme 
that is closely related to the urease-related amidohydrolase superfamily and catalyzes 
the reversible conversion of creatinine to creatine. This reaction is the first step of the 
creatinine-metabolizing pathway found in Pseudomonas putida (1). Creatine is then 
degraded by creatinase [EC 3.5.3.3] (2), sarcosine dehydrogenase [EC 1.5.3.1] (3), and 
formaldehyde dehydrogenase [EC 1.1.1.159] (4) in this microorganism. 
In mammals, creatinine is derived from creatine and creatine phosphate. A substantial 
amount of creatine phosphate is stored as a source of high-energy phosphoryl groups in 
muscle. With expanding ATP consumption, creatine kinase regenerates ATP from ADP 
and creatine phosphate. Creatinine is non-enzymatically produced at a constant rate, 
while creatine phosphate is reproduced enzymatically. Creatinine filtered out of the 
blood by the glomeruli in the kidney is excreted into urine without tubular reabsorption. 
Since the creatinine concentration in plasma is proportional to individual muscle mass, 
the creatinine clearance estimated from blood and urinary creatinine levels is important 
for renal function evaluation. At the present time, the creatine content is usually 
determined by an enzymatic method using creatininase, creatinase, and sarcosine 
oxidase.  
Creatininase was first purified from P. putida as a creatinine-degrading enzyme (1). 
Later, it was found that the enzyme activity was increased approximately 4-fold by the 
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addition of manganese (5). The gene encoding creatininase was cloned from P. putida 
and over-expressed using an E. coli system (6). Sequences with a 30% or higher identity 
to P. putida creatininase, including sequences from Arthrobacter sp., can be found in 
some bacterial genomes (7), although most of them have not been experimentally 
proven to show creatininase activity. The recombinant enzyme can be activated with 
manganese, and an Mn-activated enzyme has been applied for the diagnostic analysis of 
creatinine together with other creatinine-metabolizing enzymes. The three-dimensional 
structures of these enzymes have been reported (8-15). 
We have determined the structures of the wild-type and Mn-activated enzymes. Two 
metal ions have been found at an active site in each subunit; two zinc ions in the 
wild-type enzyme. It is known that, one of the two ions is replaced with manganese in 
the Mn-activated enzyme. In dihydroorotase [EC 3.5.2.3] (16), isoaspartyl dipeptidase 
[EC 3.4.19.5] (17), and D-aminoacylase [EC 3.5.1.81] (18), which possess binuclear 
metal-center like creatininase, the water molecule bridging the metal ions initiates the 
catalytic reaction as a nucleophile (16-21). This water molecule forms a hydrogen bond 
with an Asp residue that is conserved in these enzymes and is coordinated with one of 
the metal ions (Metal1). It has been reported that the Asp residue functions as a catalytic 
base/acid at the ring-opening reaction through mediation of the proton from the water 
molecule to the product amino group. In the creatininase, however, the Wat1 is too far 
away from the acidic residues Glu34 and Asp45 coordinating with the Metal1 to form a 
hydrogen bond, although the bridging water molecule, Wat1, also acts as the 
nucleophile. On the other hand, the residue His178 is located at a position that allows it 
to form a hydrogen bond with the Wat1. It is considered, however, that the His178 is 
also not a proton donor for the catalytic reaction because it is at too great a distance 
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from the substrate. We have proposed a novel mechanism in which a water molecule, 
Wat2, which is coordinated to the Metal1 and forms a hydrogen bond with Glu122, 
functions as the proton donor (14). 
From the structure determination of the creatininase, we also found a significant 
conformational change in the loop composed of Lys158-His178, indicating an 
open-closed conformational change upon substrate binding and that the creatinine or 
creatine were trapped in the active site as shown in Fig. 1 (14). As a result, the creatine 
is kept away from the solvent. It must be important for the catalytic reaction that the 
substrate is kept tightly in the closed active site. 
In this study, we determined the crystal structure of creatininase complexed with an 
inhibitor, 1-methylguanidine, to estimate the details of the substrate recognition. The 
site-directed mutants of Y121A, W154A, W154F, W174A, and W174F were prepared 
to clarify the functions of hydrophobic residues around the active site in the open-closed 
conformational change upon substrate binding. Furthermore, the gene of the E122Q 
mutant was prepared to clarify the function of the Wat2. Finally, we discussed the 
functions of these residues in the catalytic reaction based on an enzyme-activity assay 




Site-directed mutagenesis  
 Six amino acid residues of Tyr121, Glu122, Trp154, Trp174, His178, and Glu183 were 
selected for site-directed mutagenesis. Conformational shifts of the side chains of 
Tyr121 and Trp154 are observed in the enzyme-creatine (reaction product) complex, 
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which allow the chains to make hydrophobic contact with creatine upon its binding. 
There is also a shift of the main chain of Trp174 upon creatine binding. Glu183 is a 
ligand of metal ion. His178 and Glu122 form hydrogen bonds with Wat1 and Wat2, 
respectively (Fig. 1). These residues were well conserved among the homologous 
sequences found by a BLAST search performed with the amino acid sequence of P. 
putida creatininase, except Tyr121, which was moderately conserved and tyrosine or 
phenylalanine was found at this position in some sequences.  
 All substitutions (Y121A, E122Q, W154A, W154F, W174A, W174F, H178A and 
E183Q) were confirmed by DNA sequencing and all the mutant cre genes were 
expressed at a high level similar to that achieved for the wild-type enzyme under the 
standard condition.  
  
Binuclear metal center 
Since the creatininase has a binuclear metal center, metal ion treatment was 
included in the standard purification procedure. The enzymes that received zinc 
treatment showed significantly higher activity than those without metal treatment and 
the use of manganese chloride increased the activity yield (Table 1). Our previous study 
revealed that two zinc ions and one zinc and one manganese ion were coordinated in the 
active site of the zinc-treated and the manganese-treated enzymes, respectively. The 
zinc content of the zinc-treated enzyme was determined to be 2.2 zinc molecules per 
subunit by atomic absorption spectrometry and this enzyme was designated as the 
wild-type enzyme (Zn-Zn). In order to investigate the effect of metal ions, we tried to 
remove the zinc ions by dialyzing against buffers containing o-phenanthroline. However, 
only a partial decrease (10-30%) in activity and zinc content were observed. Then we 
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prepared the enzyme from the cell-free extracts without zinc treatment and the 
purification was carried out using buffers containing EDTA throughout the procedure to 
remove metal ions from the enzyme. The zinc content of this enzyme preparation was 
0.6 molecules per subunit. The specific activity was 178 units/mg, which was 48% of 
the activity of the wild-type enzyme (Zn-Zn); 370 units/mg. Although it was difficult to 
prepare a metal-free apoenzyme, we designated this enzyme preparation as 
semi-apoenzyme (Zn).  
The wild-type enzyme (Zn-Zn) and the semi-apoenzyme (Zn) were preincubated 
with metal ions as described in the Materials and Methods and the activity was 
measured. The results were summarized in Table 2. The preincubation with ZnCl2 had 
no effect on the activity of wild-type enzyme (Zn-Zn) and that with MnCl2 increased the 
activity by 1.7-fold. The activity of the semi-apoenzyme (Zn) was fully restored by the 
incubation with ZnCl2. Furthermore, the activity of the semi-apoenzyme (Zn) after 
preincubation with MnCl2 showed a comparable level of activity obtained for the 
wild-type enzyme purified from the cell-free extract treated with MnCl2. The specific 
activities and kcat values of the wild-type enzyme (Zn-Zn) and the semi-apoenzyme (Zn) 
are closely related to their metal contents. The manganese activation was mainly due to 
the increase in kcat, and the Km values were not substantially changed. 
The zinc content was measured for the E122Q mutant because the electron density 
corresponding to only one metal ion was observed in the crystal structure of this mutant, 
as described in detail below. The zinc content in the E122Q mutant was determined to 
be 0.85 molecules per subunit. The incubation with ZnCl2 significantly increased the 
activity, indicating that the metal affinity of this mutant was weakened. In addition, the 
incubation with MnCl2 resulted in a further increase in activity, showing significant 
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manganese activation on this mutant, although the absolute activity values were very 
low. When assay was performed in the presence of varying concentrations of metal 
chloride, the maximum activity was observed with 10 M ZnCl2 and 50 M MnCl2 for 
the wild-type enzyme. A little higher concentration was needed to obtain the maximum 
activity for the E122Q mutant enzyme than for the wild-type in our assay condition, 
suggesting that the metal affinity of the E122Q mutant enzyme was somewhat reduced. 
 
Kinetic analysis of the wild-type and mutant enzymes 
The kinetic constants for the wild-type and mutant creatininases are summarized in 
Table 1. All the mutations introduced at the 6 amino acid residues drastically decreased 
the activities of the mutant enzymes, except W174F, which retained approximately 47% 
of the activity of the wild-type enzyme (Mn-Zn). No activity was observed for the 
W154A, H178A and E183Q mutants. The Y121A and E122Q mutants showed 4.6% and 
0.03% of the activity of the wild-type enzyme (Zn-Zn), respectively. The activity of the 
E122Q mutant was partially recovered by the addition of metal ions as described above. 
On the mutations in two Trp residues, alanine substitution had a stronger effect than 
phenylalanine substitution. No and little activity was detected in W154A and W174A 
mutants, respectively. W174F mutant retained a level of activity comparable to the 
wild-type enzyme (Mn-Zn), and significant activity was observed for W154F mutant.  
 
Crystal structure of the enzyme-1-methylguanidine complex 
The enzyme-inhibitor complex was obtained by using a competitive inhibitor, 
1-methylguanidine. In all subunits, 1-methylguanidine was found in the active site, as 
shown in Fig. 2a. The structure of the enzyme-inhibitor complex including the loop 
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region from Pro160 to His178 was closer to that of the enzyme-substrate complex 
displaying the closed form (PDB code: 1V7Z) rather than that of the wild-type enzyme 
(Mn-Zn) in the open form (PDB code: 1J2T) as shown in Fig. 2b. In the 
enzyme-inhibitor complex, the 1-methylguanidine, which shares a part of a creatine 
molecule, was bound in a similar way as observed for creatine. The 1-methylguanidine 
was not coordinated with the metal ions but was bound by forming a hydrophobic 
interaction with Tyr121 and Trp154, and hydrogen bonds with the main-chain carbonyl 
groups of Ser78, Trp174, and Asp175 with distances of 2.7, 2.8, and 2.8 Å, respectively. 
There was a difference of 21.1° in the angle between the guanidine planes of creatine 
and 1-methylguanidine bound at the active site (Fig. 2c). Two metal ions, Mn and Zn, 
are located at the active site, and three water molecules, Wat1, Wat2, and Wat3, are 
coordinated to metal ions as well as the wild-type enzyme (Mn-Zn). 
 
Crystal structures of the W154A, W154F, and W174F mutants 
Two structures of W174F mutant were determined using crystals with different 
space group; W174F-P21 and W174F-P3221 at 2.0 and 1.78 Å resolution, respectively. 
The structures of W174F-P21 and W174F-P3221 were almost identical with an rms 
deviation of 0.21 Å. We are going to discuss the structure of W174F mutant using the 
W174F-P21. Structural comparisons with the open and closed form showed that the 
W174F mutant possesses the open form structure (Fig. 3a). The active-site structure of 
the W174F mutant is shown in Fig. 4. Two metal ions of Mn and Zn are located at the 
active site of the W174F mutant, and a cacodylate anion is bound to these metal ions as 
shown in Fig. 5a. Two oxygens of the cacodylate anion were located at the positions 
corresponding to Wat1 and Wat3 in the wild-type enzyme (Mn-Zn), and two oxygens 
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formed hydrogen bonds with His178 and the main-chain NH group of Tyr121 at 
distances of 2.8 and 2.6 Å, respectively. The Wat2 was coordinated to the Mn ion at a 
distance of 2.1Å, and formed a hydrogen bond with Glu122 at a distance of 2.75 Å. 
Based on the observation of an open-closed conformational change upon substrate 
binding, Trp174, which is located in the loop region at a distance of 5.3 Å from Trp154, 
moves to cover the active-site pocket and undergoes a hydrophobic interaction at a 
distance of 3.4 Å. The Trp174 forms a hydrophobic contact with Phe171 in the same 
loop region at a distance of approximately 3.5 Å. Although the W174F mutant adopts 
the open form with respect to the main-chain structure, the side chain of Phe174 was 
located at a distance of 4.6 Å from Trp154 and occupied an intermediate position 
between the open and closed forms. Additionally, the distance between Phe171 and 
Phe174 was longer than that between Phe171 and Trp174 in the wild-type enzyme. 
The structure of the W154A mutant was determined at the 2.0 Å resolution. The 
subunit structure of W154A mutant was closer to the open form (Fig. 3b). The high 
peak found at the corresponding position of the Wat1 was assigned as a chloride ion. 
The active-site structure of W154A mutant is shown in Fig. 4. Since Trp154 is one of 
the residues composing the active site pocket, the replacement to Ala resulted in wide 
exposure of the active site to the solvent. 
The structure of W154F mutant was determined at 2.0 Å resolution. The 6 subunits 
of W154F mutant can be divided into two groups: a group that includes subunits A, B, 
and C, and a group that includes subunits D, E, and F. The structures of both subunits A 
and D were closer to open form, but the structures of Val150-His178 containing the loop 
region were significantly different from each other (Fig. 3b). It was considered that the 
difference in conformation between these subunits was related to the conformational 
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change of Phe154. As shown in Fig. 4, the conformation of Phe154 in the subunit A was 
similar to that in the wild-type enzyme (Mn-Zn). As shown in Fig. 3b, the side chain 
phenyl ring of Phe154 was located at the center position of the indole ring of Trp154 in 
the wild-type enzyme (Mn-Zn). The structure of Val150-His178 was virtually identical 
to that in the open form, even though the electron density map of Glu169-Asp175 in the 
subunit A was comparatively obscure; the models of these regions were built as 
poly-Ala models. Meanwhile, the conformation of Ph154 in the subunit D was unique, 
as shown in Fig. 4. The side chain χ1 angle of Phe154 changed to -79.3° from 48.1° in 
the subunit A, and the position of Cα was altered by 1.14 Å from that in the subunit A. 
Consequently, Phe154 was accommodated into the hydrophobic pocket composed of 
Tyr153, Phe182, and Trp174. It was considered that this unique conformation of Phe154 
affected the main-chain structure of Val150-His178. A manganese and a zinc ion are 
found at the active site in all subunits, and three water molecules, Wat1, Wat2, and Wat3, 
are conserved as well as the wild-type enzyme (Mn-Zn), as shown in Fig. 5b.  
 
Crystal structures of the E122Q mutants 
In our previous paper, we hypothesized that Wat2 acts as a catalytic acid and a 
proton donor. The structure of the E122Q mutant was determined at 2.0 Å resolution. 
The subunit structure was almost identical to that of the closed form (Fig. 3c). The 
difference Fourier map corresponding to creatine was displayed at the active site of five 
subunits in the hexamer. Only one peak corresponding to zinc ion was found in the 
active site of this complex, the E122Q (Zn)-substrate complex. This result agreed with 
the zinc content (0.85 Zn/subunit) estimated from the atomic absorption spectrometry. A 
zinc ion (Metal2) coordinated with His36, Asp45 and Glu183 was identified in the 
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crystal structure but the other zinc ion (Metal1) that is bound to Glu122 through a 
hydrogen bond with Wat2 was not found (Fig. 5c). It was suggested that the negative 
charge on Glu122 is essential to bind a metal ion at the Metal1 site. The active site of 
the E122Q (Zn)-substrate complex is shown in Fig. 6. The active-site structure of the 
E122Q (Zn)-substrate complex is quite similar to that of the wild-type except for the 
occupied state of Metal1, the side-chain conformation of the 122nd residue, and the 
positions of Wat2 and creatine. In the wild-type enzyme (Mn-Zn), the conformation of 
Glu122 is stabilized by two hydrogen bonds of the side chain with main-chain NH 
group of Gln75 and itself. In the E122Q (Zn)-substrate complex, meanwhile, only a 
hydrogen bond between Gln122 and Gln75 was formed. A different hydrogen-bonding 
network may be responsible for the conformational change of Gln122. The position of 
Wat2 in the E122Q (Zn)-substrate complex is 0.88 Å away from that in the 
enzyme-substrate complex, and the distance between creatine and Wat2 in the 
E122Q-substrate complex (3.10 Å) differs little from that in the enzyme-substrate 
complex (3.04 Å). The hydrogen bond between Wat2 and Gln122 is 2.92 Å, which is 
0.26 Å longer than that between Wat2 and Glu122 in the enzyme-substrate complex. 
 The structure of E122Q mutant crystallized in the presence of MnCl2, the E122Q 
(Mn-Zn) mutant was determined at 2.2 Å resolution. The structure of the loop region 
was somewhat closer to that in the open form; however, the loop was located at an 
intermediate position between the open and closed form (Fig. 3c). The active-site 
structure of E122Q (Mn-Zn) mutant is shown in Fig. 6. In the active site of E122Q 
(Mn-Zn) mutant, two high peaks on the difference map were found at positions 
corresponding to the metal-binding sites, and these peaks were assigned as a manganese 
and a zinc ion. Additionally, an electron density map assigned as a chloride ion was 
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found on the binuclear metal center. The chloride ion was located at distances of 2.7, 3.0, 
and 3.8 Å from the manganese ion, zinc ion, and His178, respectively. Unlike the 
E122Q (Zn)-substrate complex, the conformation of Gln122, the electron density map 
of which was slightly obscure, was similar to that in the wild-type enzyme; the side 
chain of Gln122 faced the manganese ion. However, no peak corresponding to Wat2 
was found around the manganese ion at the active site in any of the subunits (Fig. 5d). 
 The structure of E122Q mutant crystallized in the presence of ZnCl2, the E122Q 
(Zn-Zn) mutant, was determined at 2.0 Å resolution. As shown in Fig. 3c, the structure 
of E122Q (Zn-Zn) mutant was closer to the closed form. It was considered that the 
closed form of E122Q (Zn-Zn) mutant was induced by the addition of creatinine during 
crystallization. Nevertheless, no electron density map that could possibly be assigned as 
creatinine or creatine was found at the active site. The active-site structure is shown in 
Fig. 6. Two zinc ions and a chloride ion were found at each subunit, and the chloride ion 
was located at distances of 3.0, 3.3, and 3.5 Å from the zinc ions on the Metal1 and 
Metal2, and His178, respectively. The electron density map of Gln122 remained 
obscure, and the side-chain conformation was disordered. Additionally, no electron 




The structure of the wild-type enzyme complexed with 1-methylguanidine was 
determined to exist as the closed form. The 1-methylguanidine was bound in the active 
site through hydrogen bonds with the main-chain carbonyl group of Ser78, Trp174, and 
Asp175 but was not coordinated with the metal ions. It is likely that these hydrogen 
 14
bonds contribute to the induction of the closed form. In addition, we focused on other 
hydrophobic residues, including Tyr121, Trp154, and Trp174, all of which showed 
conformational change upon creatine binding. The two Trp residues are located at the 
active site and underwent hydrophobic interactions with each other in the closed form. 
The Tyr121 approached the creatine by an induced fit and underwent a hydrophobic 
interaction with Cα-C of Asp175 on the loop region. The replacement of Tyr121 to Ala 
decreased the specific activity and kcat/Km value of the resultant Y121A mutant to 9.0% 
and 3.1% of that of the wild-type enzyme (Mn-Zn), respectively. The reduced activity is 
probably due to deficiency of the hydrophobic interaction between Tyr121 and Asp175. 
It is suggested that the Tyr121 is one of important residues for stabilization of the closed 
form 
Based on the mutagenesis, both the Trp154 and Trp174 residues are important for 
the activity, but Trp154 is more critical and the substitution by a small Ala residue 
abolished the activity. The crystal structures of the W154A, W154F, and W174F 
mutants were determined. Trp154 is one of the residues composing the 
substrate-binding pocket at the active site. It is evident that the replacement of Trp154 to 
Ala broadly exposes the W154A mutant to the solvent. On three subunits of the W154F 
mutant, in which a hexamer is found in an asymmetric unit, Phe154 is located at the 
same position as Trp154 in the wild-type enzyme. On the other subunits, the side chain 
of Phe154 swung outward as if stacked on Tyr153 and Phe182. As a result, the activity 
of these subunits was likely to be lost because the active sites in the last three subunits 
were exposed to solvent as in the W154A mutant. Additionally, this conformation would 
restrict the conformational change of the loop region. If the first three subunits changed 
to the closed form upon substrate binding, it is expected that the substrate could be 
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accommodated in the protein molecule. However, a low activity of W154F was 
observed even in this situation, and this result could be explained as follows. In the first 
three subunits, the side chain of Phe154 was located at the center of the indole ring on 
Trp154 in the wild-type enzyme. An increased distance from Phe154 to Trp174 at the 
closed form of these subunits would reduce the hydrophobic interaction between these 
residues. In a similar fashion, the decreased activity of the W174F mutant can be 
explained by the reduced hydrophobic interaction between Trp154 and Phe174, which 
was caused by the replacement to a smaller Phe residue from the bulky Trp residue. 
Because the change in the distance between Trp154 and Phe174 in the closed 
conformation is expected to be small, however, the activity may be retained in the 
W174F mutant compared with the W154F mutant. From these results, it is considered 
that the hydrophobic residues around the active site are involved in the stabilization of 
the closed form through binding of the loop region by the hydrophobic interaction 
between them.  
In the scheme proposed in Fig. 7, a catalytic mechanism would explain the 
ring-opening reaction of creatinine. The reaction would be initiated by the nucleophilic 
attack of the water molecule (Wat1), which is activated as a hydroxide ion by the 
binuclear metal center. The Wat1 attacks to the carbonyl carbon of the creatinine to form 
a tetrahedral intermediate. In the second step, the carbon-nitrogen bond of the 
intermediate is cleaved with receiving a proton from the water molecule (Wat2) bound 
to Glu122. Herein, the product, creatine, is bound to the binuclear metal center through 
the carboxyl group. The enzyme can turn over by releasing a product with the 
conformational change, and recoordination and activation of a water molecule (Wat1) 
takes place on the binuclear metal center.  
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The 1-methylguanidine was bound to the active site in the same fashion as the 
creatine. However, the plane of the 1-methylguanidine was not superimposed on the 
position of the 1-methylguanidyl portion of the creatine (Fig. 2c). A model of a 
creatinine complex was built by superimposing a creatinine onto the 1-methylgunidine. 
In this model, the carbonyl oxygen of the creatinine would be coordinated to the Metal1 
and the carbonyl carbon would be located at a position suitable to receive the 
nucleophilic attack, indicating that the model is consistent with our proposed catalytic 
mechanism and that it adequately reflects the structure of the enzyme-creatinine 
complex.  
In the present study, we suggested that two water molecules (Wat1 and Wat2) had a 
critical function in the catalytic reaction. The first step in our proposed mechanism is 
the same as the nucleophilic attack by the hydroxide ion (Wat1) in the proposed 
mechanism of the urease-related amidohydrolase superfamily (14). In the mechanism of 
creatininase, however, the second step was different from that in the superfamily 
enzymes, which include dihydroorotase [EC 3.5.2.3], isoaspartyl dipeptidase [EC 
3.4.19.5] and D-aminoacylase [EC 3.5.1.81]. In these enzymes, it has been reported that 
the conserved Asp residue acts directly as a proton donor for the bond cleavage reaction 
(16-18). No residue corresponding to this Asp is conserved in creatininases. We propose 
that the water molecule (Wat2), which coordinated to Mn and formed a hydrogen bond 
with Glu122, would act as a proton donor in the catalytic reaction. 
In order to clarify the functions of the Wat2 and Glu122, Glu122 was replaced by 
glutamine by site-directed mutagenesis. The specific activity of the E122Q (Zn) mutant 
was less than 0.1% of that of the wild-type enzyme (Zn-Zn). From the crystal structure 
of the E122Q (Zn)-substrate complex, it was revealed that one of the binuclear metal 
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centers, Metal1, was deficient, indicating that the Glu122 is an important residue for 
tight binding of the Metal1 ion to the active site and that the side-chain carboxyl group 
is likely to be deprotonated in the wild-type enzyme. As shown in Table 3, although the 
activity of E122Q mutant enzyme was very low, the same extent of manganese 
activation could be observed, indicating that the active site of this mutant was still 
related to that of the wild-type enzyme. The effect on Km was small and the large 
decrease in kcat was the major cause of the activity decrease. The high Fourier peaks 
were found at each active site of the E122Q mutants after the addition of either MnCl2 
or ZnCl2. These positions were overlapped with the position of the Metal1 site in the 
wild-type enzyme. In both E122Q mutants (Mn or Zn), a high peak was found on the 
binuclear metal center and was assigned as a chloride ion. This ion would have been 
taken up into the active site together with a metal ion. Although the wild-type enzyme, 
purified in the presence of EDTA, showed only half the activity of the wild-type 
enzyme (Zn-Zn), the activity was recovered by the addition of ZnCl2 or MnCl2. Activity 
was measured in the presence of various concentrations of potassium chloride and no 
change in activity was observed with potassium chloride concentration up to 100 mM. It 
is considered that the chloride ion has no effect on the enzyme activity and the drastic 
decrease in the activity of E122Q mutant is caused by a reason other than this chloride 
ion.  
The Fourier peak corresponding to the Wat2 was not found at the active site in the 
E122Q mutant that contained two metal ions. Although the conformation of Gln122 in 
the E122Q (Zn)-substrate complex was different from that of the wild-type enzyme, the 
Gln122 in the E122Q (Mn-Zn) mutant would try to adopt the same conformation as in 
the wild-type enzyme upon binding the Metal1 to the active site. Because of the 
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intra-residual steric hindrance between the main-chain and side-chain amide groups, 
however, it would be difficult to form the same conformation as in the wild-type 
enzyme. Consequently, the E122Q mutant with two metal ions may lose the Wat2 from 
the active site. It is quite likely that the decreased activity of the E122Q mutant is 
caused by a deficiency of the Wat2 on the active site. The Wat2 is necessarily important 
in the catalytic reaction, and thus we conclude that the Glu122 and the Wat2 play 
critical roles. 
 
MATERIALS AND METHODS 
 
Materials 
Restriction endonucleases, DNA modification enzymes, and a Mutan®-Super express 
Km kit were purchased from TaKaRa Shuzo (Otsu, Japan). The oligonucleotide primers 
containing the desired mutations were synthesized by Sigma Genosys Japan (Ishikari, 
Japan) and Genenet (Fukuoka, Japan). The BigDye terminator cycle sequencing kit and 
other reagents used for sequencing were obtained from Applied Biosystems Japan 
(Tokyo, Japan). Toyopearl HW65C, Toyopearl Butyl 650C, and DEAE-Toyopearl 650 
were purchased from Tosoh (Tokyo, Japan). Creatinine, creatine, lithium sulfate 
monohydrate, and 1-methylguanidine were purchased from Nacalai Tesque, Inc. (Kyoto, 
Japan). 
 
Bacterial strains, plasmids, and media 
E. coli MV1184 (ara-, (lac-proAB), rpsL, thi-, 80dlacZM15, (srl-recA) 
306: :Tn10, (F’, traD36, proAB, lacIqlacZM15)) was used for site-directed 
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mutagenesis. E. coli DH5 (F- , 80dlacZM15, (lacZYA-argF) U169, deoR, recA1, 
endA1, hsdR17 (rk
-, mk
+), phoA, supE44, λ-, thi-1, gryA96, relA1) and XL1-Blue 
(recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac [F’, proAB, lacIqZM15, 
Tn10 (Tetr)]) were used for expression. Plasmids pKF19k and pUC19 were used for 
mutagenesis and expression. Bacteria were grown in Luria-Bertani broth (LB-broth).  
 
Construction of the site-directed mutant gene 
Two methods were used for site-directed mutagenesis. Construction of E122Q, 
W154A, H178A and E183Q mutants was carried out by using a Mutan®-Super Express 
Km kit according to the manufacturer’s instructions. Mutagenic primers used were 
H178A: 5’-GGACATCGAGGCCGGCGGCGTC-3’, E183Q: 
5’-GGCGGCGTCTTGCAGACCTCCCTG-3’, and W154F: 
5’-GCTCTCCTACTTCGACTTCGTC-3’. Alternatively, the megaprimer-based PCR 
mutagenesis strategy (22) was used for the construction of Y121A, W154F, W174A and 
W174F. Flanking primers (cre198-217s: 5’- GCAAGCGGTCGCCGAGCG-3’ and 
cre748-767a: 5’- CCAGCATCCACGACCTTC-3’) were used with mutagenic primers; 
E122Q: 5’-ACGGCCACTACCAAAATTCCATG-3’, W174A: 
5’-GCTCTCCTACGCGGACTTCGTCA-3’, W174A: 
5’-TCCTCGGCGCGGACATCGAG-3’, and W174F: 
5’-TTCCTCGGCTTCGACATCGAG-3’. All the mutations were confirmed by 
sequencing and the mutant enzymes were expressed under essentially the same 




Purification of the wild-type and mutant enzymes 
Expression and purification of the wild-type and mutant enzymes were carried out 
using the method described previously (14). For the Mn-activated wild-type enzyme 
and W154A, W154F, and W174F mutants, 1 M MnCl2 solution was added to the 
supernatant to give a 8% (v/v) concentration before the protamine treatment. For the 
wild type enzyme (Zn-Zn), 1 M ZnCl2 solution was used. The solutions containing 
metal chloride were stirred for 30 min at room temperature and then centrifuged 
(22540g, 30 min, and 4˚C). The Toyopearl Butyl-650C column was substituted for the 
Toyopearl HW65C column. Enzymes adsorbed to the column were eluted with a linear 
gradient of 35% to 0% saturated ammonium sulfate in 20 mM potassium phosphate 
buffer (pH 7.5). The Y121A and E122Q mutant enzymes were purified using the same 
procedure without any metal treatment. For preparation of the apo-type of the wild-type 
enzyme, purification was carried out using the same buffers containing 10 mM EDTA 
throughout the purification procedure. 
The purity of the enzymes was determined by SDS-PAGE. All enzyme solutions were 
dialyzed against 2 mM potassium phosphate buffer (pH 7.5) and concentrated using a 
Centriprep YM-30 (Millipore, Bedford, MA). 
 
Atomic absorption spectrometry 
Sample solutions for atomic absorption spectrometry were prepared with a wet 
digestion method. Up to 0.2 ml of enzyme solution was supplemented with 2.5 ml of 
concentrated nitric acid, then heated gradually to 140˚C and kept at that temperature for 
10 min. After allowing the solution to cool down to room temperature, 0.5 ml of 
perchloric acid was added to digest the sample, and then heated for 1 h at 140˚C, for 30 
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min at 160˚C, and finally for 15 min at 175˚C. The solution was allowed to return to 
room temperature, and 0.5 ml of water was added. The solution was heated for 20 min 
at 140˚C. Then the temperature was elevated to 170˚C until white smoke appeared. This 
heating step with water was repeated again. The volume of the digested solution was 
adjusted to 10 ml by 0.1 M HCl. The zinc contents of the wild-type enzyme (Zn-Zn), 
semi-apoenzyme (Zn), and E122Q mutant enzyme were determined by a flame atomic 
absorption spectrometer AAnalyst 200 (Perkin Elmer, Foster City, CA). 
 
Enzyme activity assay and kinetic studies 
Enzyme activity was determined by measuring the amount of creatinine produced 
from creatine as a substrate using the Jaffe reaction (5, 14). The activity was estimated 
using a molar extinction coefficient of 4650 M-1cm-1 at 520 nm. To determine the Km 
values, the creatine concentration was varied and Lineweaver-Burk plots were used to 
calculate Km and the apparent Vmax. The enzyme concentration was estimated based on a 
molar extinction coefficient of 28590 M-1cm-1 and a molecular weight of 27926, and the 
kcat was calculated. 
Effect of metal ions was investigated by preincubating the enzyme with metal ions 
before activity assay. The enzyme solutions were incubated for 15 min at room 
temperature in the presence of 0.1 mM ZnCl2 or 0.1 mM MnCl2 and the activity was 
determined by the standard protocol. Alternatively, assay was carried out in the presence 
of varying concentrations of metal chloride.  
 
Crystallizations and X-ray data collections 
Crystals of the enzyme-inhibitor complex were obtained by the hanging-drop 
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vapor-diffusion method at 20°C. A droplet was prepared by mixing an equal volume of 
25 mg/ml Mn-activated enzyme solution and a reservoir solution containing 1.5 M 
lithium sulfate, 0.1 M HEPES buffer (pH 7.5), and 5 mM 1-methylguanidine. The 
E122Q (Zn)-substrate complex was crystallized by the sitting-drop vapor-diffusion 
method at 5°C using 50 mg/ml E122Q mutant enzyme solution and a reservoir solution 
containing 1.6 M lithium sulfate, 0.1 M HEPES buffer (pH 7.5) and 120 mM creatinine. 
The data of the enzyme-inhibitor complex and the E122Q (Zn)-substrate complex were 
collected using synchrotron radiation with a wavelength of 1.000 Å with a MAR CCD 
165 detector at the BL41XU station of SPring-8 (Hyogo, Japan) and with an ADSC 
Quantum 4R detector at the BL6A station of the Photon Factory (Tsukuba, Japan), 
respectively. These crystals were isomorphous with those of the Mn-activated 
creatininase and its creatine complex (PDB code: 1J2T and 1V7Z, 14). 
We screened for new conditions for the crystallization of W154A, W154F, and 
W174F mutants by the hanging-drop vapor diffusion method at 20°C using 25 mg/ml 
mutant-enzyme solution. Crystals were obtained with a reservoir solution containing 
42-48% (v/v) PEG200, 10-20 mM MgCl2, and 100 mM Na cacodylate buffer (pH 6.0) 
or 100 mM MES buffer (pH 6.0). Two kinds of crystals appeared under this condition; 
one was a plate-shaped crystal belonging to the space group P21, and the other was a 
partial merohedral twin crystal with a hexagonal-column shape belonging to the space 
group P3121 or P3221. The data of plate-shaped crystals for the W174F and W154A 
mutants were collected at the Photon Factory BL6A station and the data of twin crystals 
for the W174F and W154F mutants were collected with ADSC Quantum 315 and 
Quantum 210R CCD systems at the Photon Factory BL5A and the PF-AR NW-12 
stations, respectively. A crystal of the E122Q mutant treated with MnCl2 (E122Q 
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(Mn-Zn)) was obtained under the same conditions using PEG200 as the precipitant and 
25 mg/ml enzyme solution containing 1 mM MnCl2. The data for this crystal were 
collected at the PF-AR NW12 station. Crystals of the E122Q mutant treated with ZnCl2 
(E122Q (Zn-Zn) were also obtained under the same conditions. However, none of the 
data collected for these crystals were of sufficiently high quality. Therefore, crystals of 
E122Q (Zn-Zn) were obtained using 46-48% (v/v) PEG200, 10 mM MgSO4, 100 mM 
MES buffer (pH6.0), and 100 mM creatinine. The data were collected at the Photon 
Factory BL5A station.  
 The data of W154A were processed with the programs MOSFLM and SCALA in the 
CCP4 program suites (23), and the others were processed and scaled with the program 
HKL2000 (24). The statistics of crystallization conditions, crystallographic parameters, 
and data collection are summarized in Table 3. 
 
Structure determinations and refinements 
The model building was performed using the programs XTALVIEW (25) and COOT 
(26). The coordinate of Mn-activated creatininase was used for the initial model of the 
enzyme-inhibitor complex. The structure of the enzyme-inhibitor complex was refined 
by simulated annealing and energy minimization with the program CNS (27) using the 
data obtained from 20 to 1.9 Å resolution. No particular restraints for metal 
coordination were applied to the groups through the refinement procedure. The structure 
was examined by inspecting the composite omit map. The difference Fourier map 
clearly displayed a residual electron density corresponding to 1-methylguanidine bound 
at the active site. Refinement and model rebuilding were alternatively carried out over 
several cycles. Then water molecules were selected on the basis of the peak height and 
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the distance criteria from the difference Fourier map. Further model building and 
refinement cycles gave an R-factor of 19.2% and an R-free value of 20.7% using 
203,364 reflections from 20 to 1.9 Å resolution. The maximal thermal factor of the 
water molecules was 50 Å2. The same refinement procedure was applied to the E122Q 
(Zn)-substrate complex. Only one peak, which corresponds to one of two metal ions, 
was found in each active site from the difference Fourier map. Additionally, the 
difference map displayed a residual electron density corresponding to a creatine in the 
active site at five subunits of hexamer. From the results of model building and 
refinement cycles, the R-factor and R-free value decreased to 19.9% and 21.7%, 
respectively. The maximal thermal factor of the water molecules was 50 Å2. 
Two different crystals of the W174F mutant were obtained under the new conditions. 
One was a crystal belonging to space group P21 with the following cell constants: a = 
105.9 Å, b = 59.7 Å, c = 145.1 Å, β = 99.7°. One hexamer is found in an asymmetric 
unit of this crystal, and approximately 53% of the crystal volume is occupied by solvent. 
The crystal structure of the W174F mutant (W174F-P21) was determined by the 
molecular replacement method with the program PHASER in the CCP4 program suite 
(23) using the structure of the Mn-activated enzyme as the search model. The structure 
was refined with the program CNS (27) using the data obtained from 20 to 2.0 Å 
resolution. A residual density map on the binuclear metal center was clearly displayed at 
the active site of each subunit, and these were designated as a cacodylate anion by the 
corresponding tetrahedral shape, size, and peak, and the possible interactions of the 
peak with the enzyme. After addition of water molecules on the basis of residual peaks 
on the difference Fourier map, further model building and refinement cycles gave an 
R-factor of 19.6% and an Rfree of 22.9%. The maximum thermal factor of the water 
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molecules was 59 Å2. The other crystal is a partial merohedral twin crystal belonging to 
space group P3121 or P3221 with the following cell constants: a = b = 164.3 Å, c = 
163.9 Å. One hexamer is found in an asymmetric unit, and approximately 67% of the 
crystal volume is occupied by solvent. The twin fraction was estimated to be 0.463 (28). 
The crystal structure was determined by the molecular replacement method with the 
program PHASER using the coordinates of 1J2T as the search model at the space group 
P3221. A residual density map found at the active site in each subunit was designated a 
cacodylate anion. After several refinement and model building cycles using the same 
procedure as for W174F-P21, the structure of W174F-P3221 was refined to decrease the 
R-factor to 23.5% and R-free value to 25.8% using diffraction data from 20 to 1.78 Å 
resolution. The maximum thermal factor of the water molecules was 32 Å2.  
The structure of the W154A mutant was determined and refined with the same 
procedure using the coordinates of W174F-P21 as an initial model. In each active site, a 
high peak on the difference Fourier map was found. However, the position was slightly 
different from the cacodylate anion in W174F-P21. From the peak height and shape, this 
peak was designated as a chloride ion. After several refinement and model building 
cycles, the structure of the W154A mutant was refined to decrease the R-factor to 19.9% 
and the R-free value to 23.1% using diffraction data from 20 to 1.78 Å resolution. The 
maximum thermal factor of the water molecules was 58 Å2. The crystal structure of the 
W154F mutant with the space group P3221 was determined and refined with the same 
procedure using the coordinates of W174F-P3221 as an initial model by estimating the 
twin fraction of 0.397. From the difference Fourier map, a peak assigned as a water 
molecule was found on the center of the binuclear metal center. Further refinements and 
model building cycles were carried out, and the R-factor and R-free value of the model 
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were decreased to 19.9% and 21.6% using data from 20 to 2.0 Å resolution, respectively. 
The maximum thermal factor of the water molecules was 26 Å2. The structures of the 
E122Q (Mn-Zn) and E122Q (Zn-Zn) mutants were determined and refined using the 
coordinates of W174F-P3221 as an initial model by estimating the twin fractions of 
0.421 and 0.467, respectively. Unlike the E122Q (Zn)-substrate complex, two peaks 
corresponding to the binuclear metal center were found at each active site. A peak on 
the center of binuclear metal ions was designated as a chloride ion from the peak height 
and shape on the difference map. The structures of E122Q (Mn-Zn) and E122Q (Zn-Zn) 
mutants were refined to have an R-factor and R-free value of 20.6% and 23.6% at 2.2 Å 
resolution, and of 23.5% and 25.9% at 2.0 Å resolution, respectively. The maximum 
thermal factor of the water molecules was 42 and 34 Å2, respectively. 
The refinement statistics are summarized in Table 3. All diagrams are drawn with the 
program POVScript+ (29) and rendered with the program POV-Ray 
(http://www.povray.org). 
 
PDB accession codes 
The atomic coordinates and structure factors for the wild-type enzyme complexed with 
1-methylguanidine, W174F mutant enzyme with the space group P21 and P3221, 
W154F mutant enzyme, W154A mutant enzyme, E122Q (Zn) mutant enzyme 
complexed with creatine, E122Q (Mn-Zn) mutant enzyme, and E122Q (Zn-Zn) mutant 
enzyme (PDB codes: 3A6D, 3A6E, 3A6F, 3A6G, 3A6H, 3A6J, 3A6K, and 3A6L) have 
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Fig. 1 Stereo diagram of the active site with the open-closed conformational change. 
Structures of the active site superimposed between the wild-type creatininase (1J2T) in 
the open form and the creatine complex (1V7Z) in the closed form are shown as ribbon 
and stick models. The loop region, Tyr121 and Trp154 with different conformations 
between the open and closed form are represented by cyan and yellow, respectively. 
 
Fig. 2 The active-site structure of the enzyme-inhibitor complex. 
(a) Stereo diagram of the active site with the Fo-Fc omit map contoured at the 3σ level. 
The active site of the enzyme-inhibitor complex is shown as a ribbon and stick model. 
The electron density map was calculated by omitting structure factors from Mn, Zn, 
1-methylguanidine, and three water molecules using diffraction data of 20-1.9 
resolution. (b) Superimposed diagram of the three active sites. The loop region, Tyr121, 
and Trp154 involved in the conformational change at the wild-type enzyme (1J2T), the 
enzyme-substrate complex (1V7Z), and the enzyme-inhibitor complex are represented 
by cyan, yellow, and orange, respectively. Water molecules in the wild-type enzyme, the 
enzyme-substrate complex, and the enzyme-inhibitor complex are represented by red, 
yellow, and orange balls, respectively. (c) Side view of the active site superimposing the 
enzyme-inhibitor complex onto the enzyme-substrate complex. Stick models of creatine 
and 1-methylguanidine are represented by yellow and orange, respectively. The dihedral 




Fig. 3 Stereo diagram superimposing the main-chain structures among the wild-type and 
mutant enzymes. 
(a) Ribbon diagram of the structures of the enzyme-substrate complex (yellow), the 
W174F-P21 mutant (slate-blue), and the W174F-P3221 mutant (blue) superimposed 
onto the wild-type enzyme (cyan). (b) Ribbon diagram of the structures of the 
enzyme-substrate complex (yellow), the W154A mutant (red), the W154F 
mutant-subunit A (pink), and the W154F mutant-subunit D (magenta) superimposed 
onto the wild-type enzyme (cyan). (c) Ribbon diagram of the structures of the 
enzyme-substrate complex (yellow), the E122Q (Mn-Zn) mutant (green), the E122Q 
(Zn-Zn) mutant (slate-grey), and E122Q (Zn)-substrate complex (dark-green) 
superimposed onto the wild-type enzyme (cyan). 
 
Fig. 4 Stereo diagram superimposing active sites among the W174F, W154A, W154F 
mutants. 
Active sites of subunit A in the W174F, W154A, and W154F mutants and subunit D in 
the W154F mutant are represented with slate-blue, red, pink, and magenta, respectively. 
In the subunit A of the W154F mutaunt, the conformation of Phe154 is almost the same 
as that of Trp154 in the wild-type enzyme or W174F mutant. However, Phe154 in the 
subunit D is accommodated into a hydrophobic pocket composed of Tyr153, Phe182 
and Trp174 as a result of the conformational change. 
 
Fig. 5 Stereo diagrams of the active center with the Fo-Fc omit map contoured at 2 
sigma levels. 
(a) Active site of the W174F mutant is shown by a ribbon and stick model. A cacodylate 
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anion is bound to the binuclear metal center, but the Wat2 is conserved and coordinated 
to the manganese. (b) Active site of the W154F mutant. Three water molecules, Wat1, 
Wat2 and Wat3, are bound to the active site as well as those in the wild-type enzyme.  
(c) Active site of the E122Q (Zn)-substrate complex. Peaks from one of two metal ions 
and creatine were displayed on the electron density map. Although the Wat2 was bound 
to the active site, the conformation of Gln122 was different from (d) that of E122Q 
(Mn-Zn) mutant. 
 
Fig. 6 Stereo diagram of active sites in the E122Q mutants. 
Active sites of the E122Q (Zn)-substrate complex, E122Q (Mn-Zn) mutant, and E122Q 
(Zn-Zn) mutant (c) are superimposed each other, and these are represented with 
dark-green, green, and slate-grey, respectively. 
 








































Table 1 Activities of the wild-type and various mutant creatininases. 
Enzyme Treatment1 Specific activity Kinetic paremeters 
  (units/mg) Km kcat kcat/Km 
   (mM-1) (sec-1) (mM-1sec-1) 
Wild-type ZnCl2 370 ± 4 44 252 5.73 
 MnCl2 1560 ± 10 77 1340 17.4 
(semi-apo) EDTA2 178 ± 8 150 222 1.48 
Y121A MnCl2 140 ± 1.2 160 86 0.54 
E122Q ZnCl2 0.13 ± 0.03 220 1.5 0.008 
W154A MnCl2 No activity - - - 
W154F MnCl2 4.9 ± 0.3 350 178 0.51 
W174A MnCl2 Very low activity - - - 
W174F MnCl2 740 ± 2 90   688 7.64 
H178A MnCl2 No activity - - - 
E183Q MnCl2 No activity - - - 
1Either ZnCl2, or MnCl2 was added to the crude extracts before the addition of protamine sulfate as described in the materials and methods. 2EDTA was included in 
all the buffers used for this enzyme preparation as described in the materials and methods. Activity assay was carried out with creatine as a substrate and the 
creatinine formed was determined by the Jaffe method.  
 
Table 2 Effect of metal ions on the activity of the wild-type and the E122Q mutant creatininases. 
Enzyme Metal treatment 
 ZnCl2  MnCl2 
 Specific activity Km kcat kcat/Km  Specific activity Km kcat kcat/Km 
 (units/mg) (mM-1) (sec-1) (mM-1sec-1)  (units/mg) (mM-1) (sec-1) (mM-1sec-1) 
wild-type enzyme (Zn-Zn) 376 ± 2 46 264 5.74  640 ± 38 46 437 9.5 
semi-apoenzyme (Zn) 445 ± 9 32 280 8.75  1661 ± 41 70 1380 19.7 
E122Q 3.1 ± 0.2 77 2.9 0.04  13.9 ± 0.6 56 11 0.20 
 
Table 3 Data collection and Refinement statistics. 
 
Data set enzyme-inhibitor W174F W174F W154F W154A E122Q (Zn) E122Q (Mn-Zn) E122Q (Zn-Zn) 
 complex mutant mutant mutant mutant -substrate   mutant mutant 
       complex 
PDB code 3A6D 3A6E 3A6F 3A6G 3A6H 3A6J 3A6K 3A6L
Data Collection 
X-ray source SPring-8 BL41XU PF BL6A PF BL5A PF AR-NW12 PF BL6A PF BL6A PF AR-NW12 PF BL5A 
Wavelength (Å) 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
Space group P212121 P21 P3221 P3221 P21 P212121 P3221 P3221 
Cell parameter 
 a (Å) 102.4 105.9 164.3 164.5 106.8 102.2 164.2 164.4 
 b (Å) 152.7 59.7 (164.3) (164.5) 60.2 152.7 (164.2) (164.4) 
 c (Å) 167.5 145.1 163.9 164.1 146.2 166.9 164.7 164.6 
  β = 99.7°   β = 100.3°    
 Resolution range (Å) 50-1.90 50-1.97 50-1.78 50-2.0 40-2.0 20-2.0 50-2.2 50-2.0 
 (1.97-1.90) (2.06-1.97) (1.84-1.78) (2.07-2.00) (2.11-2.00) (2.07-2.00)) (2.28-2.20) (2.07-2.00 
 # of unique reflections 203,658 123,961 242,993 173,119 121,694 175,702 128,840 172,594 
 (18,439) (11,025) (24,075) (17,129) (17,141) (17,360) (12,713) (17,108) 
 Completeness (%) 98.8 (90.3) 97.6(87.3) 99.9 (99.8) 100 (100) 98.1(95.3) 100 (100) 99.3 (98.8) 99.9 (100) 
 Redundancy 6.8 (4.4) 3.8 (3.7) 11.1 (10.0) 11.3 (11.2) 3.0(2.7) 7.3 (7.1) 11.3 (11.3) 11.2 (11.1) 
 Mean I/(I) 33.6 (2.8) 34.8 (10.6) 41.8 (5.6) 42.3 (9.5) 12.0 (3.1) 33.1 (6.2) 24.2 (2.9) 37.7 (6.5) 
 Rmerge 0.064 (0.285) 0.056 (0.161) 0.079 (0.242) 0.070 (0.229) 6.8 (30.7) 0.072 (0.261) 0.118 (0.355) 0.080 (0.311) 
twin factor - - 0.463 0.370 - - 0.421 0.467 
Refinement 
 Resolution range (Å) 20-1.9 20-2.00 20-1.78 20-2.0 20-2.00 20-2.0 20-2.2 20-2.0 
 R-factor 0.192 0.197 0.235 0.199 0.198 0.199 0.206 0.235 
 Rfree 0.207 0.229 0.258 0.216 0.231 0.217 0.236 0.259 
average B-factor 
 main chain atoms (Å2) 28.3 22.1 22.0 19.1 26.6 24.1 38.7 27.8 
 side chain atoms (Å2) 30.4 24.2 23.8 21.3 28.5 26.0 40.0 29.5 
 metal ions (Å2) 26.4 29.4 31.0 28.0 41.4 22.2 37.0 25.9 
 binding ions or molecules 
  to the active site  (Å2) 42.0 (inhibitor) 30.7 (cacodylate) 35.3 (cacodylate) - 35.9 (chloride) 40.1 (substrate) 49.8 (chloride) 35.4 (chloride) 
water molecules (Å2) 35.7 29.5 31.6 25.8 30.2 30.4 42.0 33.9 
RMSDs 
 Bond lengths (Å) 0.005 0.005 0.006 0.005 0.005 0.005 0.006 0.006 
 Bond angles (deg.) 1.26 1.22 1.24 1.22 1.23 1.27 1.22 1.26
Values in parentheses refer to the last resolution shell. Through refinement procedure, occupancy of 1.0 was used for binding ions or molecules to the active site.  
